Treatment of Movement Disorder Emergencies

Neurotherapeutics

Volumn 11, Issue 1, 2014, Pages 208-212

  Frucht, Steven J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Deep brain stimulation; Dystonic storm; Emergency; Neuroleptic malignant syndrome; Parkinsonism

Indexed keywords

NEUROLEPTIC AGENT;

ABDUCTOR PARESIS; CHOREA MINOR; DYSTONIA; DYSTONIC STORM; EMERGENCY CARE; HEMIBALLISM; HUMAN; HYPERPYREXIA; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; NEUROLEPTIC MALIGNANT SYNDROME; PARESIS; PARKINSON DISEASE; PARKINSONISM; PATIENT CARE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SHY DRAGER SYNDROME;

DISEASE MANAGEMENT; EMERGENCIES; HUMANS; MOVEMENT DISORDERS;

EID: 84893040118     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-013-0240-3     Document Type: Review

References (40)

1. Poston KL, Frucht SJ. Movement disorder emergencies. J Neurol 2008;255(Suppl. 4): 2-13.
2. Frucht SJ (ed.). Movement disorder emergencies, diagnosis and treatment, 2nd ed. Humana Press, New York, 2013.
3. Bhatt MG, Elias MA, Mankodi AK. Acute and reversible parkinsonism due to organophosphate pesticide intoxication: five cases. Neurology 1999;52: 1467-1471.
4. Rail D, Scholtz C, Swash M. Post-encephalitic parkinsonism: current experience. J Neurol Neurosurg Psychiatry 1981;44: 670-676.
5. Ogata A, Tashiro K, Pradhan S. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology 1999;53: 1781-1786.
6. Lockman LA, Sung JH, Krivit W. Acute parkinsonian syndrome with demyelinating leukoencephalopathy in bone marrow transplant recipients. Pediatr Neurol 1991;7: 457-463.
7. Chuang C, Constantino A, Balmaceda C, Eidelberg D, Frucht SJ. Chemotherapy-induced parkinsonism responsive to levodopa: an under-recognized entity. Mov Disord 2003;18: 328-331.
8. Bower JH, Muenter MD. Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma. Mov Disord 1995;10: 681-682.
9. Jankovic J, Newmark M, Peter P. Parkinsonism and acquired hydrocephalus. Mov Disord 1986;1: 59-64.
10. Sacks O. Awakenings. Harper Perennial, New York, 1990.
11. Friedman JH, Feinberg SS, Feldman RG. A Neuroleptic malignant-like syndrome due to levodopa therapy withdrawal. JAMA 1985;15: 2792-2795.
12. Granner MA, Wooten GF. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome. Semin Neurol 1991;11: 28-235.
13. Mizuta E, Yamasaki S, Nakatake M, Kuno S. Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period. Neurology 1993;43: 1048-1049.
14. Kadowaki T, Hashimoto K, Suzuki K, Watanabe Y, Hirata K. Case report: recurrent parkinsonism-hyperpyrexia syndrome following discontinuation of subthalamic deep brain stimulation. Mov Disord 2011;26: 1561-1562.
15. Kuno S, Mizuta E, Yamasaki S. Neuroleptic malignant syndrome in parkinsonian patients: risk factors. Eur Neurol 1997;38: 56-59.
16. Sato Y, Asoh T, Metoki N, Satoh K. Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;74: 574-576.
17. Gurrera RJ, Caroff SN, Cohen A, et al. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry 2011;72: 1222-1228.
18. Rodriguez ME, Luquin MR, Lera G, Delgado G, Salazar JM, Obeso JA. Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion. Mov Disord 1990;5: 170-172.
19. Wang HC, Hsieh Y. Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy. Mov Disord 2001;16: 765-767.
20. Addonizio G, Susman VL. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. J Clin Psych 1987;48: 102-105.
21. Vaughan CL, Goldman JG. Psychosis and Parkinson's disease. In: Frucht SJ (ed.) Movement disorder emergencies: Diagnosis and treatment. Humana Press, New York, 2013, pp. 75-92.
22. Hanson DG, Ludlow CL, Bassich CJ. Vocal fold paresis in Shy-Drager syndrome. Ann Otol Rhinol Laryngol 1983;92: 85-90.
23. Silber MH, Levine S. Stridor and death in multiple system atrophy. Mov Disord 2000;15: 699-704.
24. Isozaki E, Matsubara S, Hayashida T, Oda M, Hirai S. Morphometric study of nucleus ambiguous in multiple system atrophy presenting with vocal cord abductor paralysis. Clin Neuropathol 2000;19: 213-220.
25. Isozaki E, Osanai R, Horiguchi S, et al. Laryngeal electromyography with separated surface electrodes in patients with multiple system atrophy presenting with vocal cord paralysis. J Neurol 1994;241: 551-556.
26. Iranzo A, Santamaria J, Toloza E. Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Lancet 2000;356: 1329-1330.
27. Ptok M, Schonweiler R. Botulinum toxin type A-induced "rebalancing" in bilateral vocal cord paralysis? HNO 2001;49: 548-552.
28. 2 in bilateral recurrent paralysis. Ann Otolaryngol Chir Cervicofac 1992;109: 235-239.
29. Jankovic J, Penn AS. Severe dystonia and myoglobinuria. Neurology 1982;32: 1195-1197.
30. Manji H, Howard RS, Miller DH, et al. Status dystonicus: the syndrome and its management. Brain 1998;121: 243-252.
31. Dalvi A, Fahn S, Ford B. Intrathecal baclofen in the treatment of dystonic storm. Mov Disord 1998;13: 611-612.
32. Grandas F, Fernandez-Carballal C, Guzman-de-Villoria J, Ampuero I. Treatment of a dystonic storm with pallidal stimulation in a patient with PANK2 mutation. Mov Disord 2011;26: 921-922.
33. Koek RJ, Pi EH. Acute laryngeal dystonic reactions to neuroleptics. Psychosomatics 1989;30: 359-364.
34. Sacks OW, Kohl M. L-dopa and oculogyric crises. Lancet 1970;2: 215-216.
35. Ristic A Marinkovic J, Dragasevic N, Stanisavljevic D, Kostic V. Long-term prognosis of vascular hemiballismus. Stroke 2002;33: 2109-2111.
36. Postuma RB, Lang AE. Hemballism-hemichorea. In: Frucht SJ (ed.) Movement disorder emergencies: Diagnosis and treatment. Humana Press, New York, 2013, pp. 151-161.
37. Sitburana O, Ondo WG. Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus. Mov Disord 2006;21: 2023-2025.
38. Krauss JK, Pohle T, Borremans JJ. Hemichorea and hemiballism associated with contralateral hemiparesis and ipsilateral basal ganglia lesions. Mov Disord 1999;14: 497-501.
39. Fusco C, Ucchino V, Frattini D, Pisani F, Della Giustina E. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham's chorea. Eur J Paediatr Neurol 2012;16: 373-378.
40. Walker K, Brink A, Lawrenson J, Mathiassen W, Wilmshurst JM. Treatment of Sydenham chorea with intravenous immunoglobulin. J Child Neurol 2012;27: 147-155.